ENETS-NANETS Webinar 2024

The ENETS Education Board is delighted to offer a joint webinar in collaboration with the North American Neuroendocrine Tumor Society NANETS. This joint effort brings together leading experts from both societies, offering a unique opportunity to gain insights and knowledge from top professionals in the field.

Covering a range of hot topics, this webinar is divided into three parts, airing on two dates: 26 June and 10 July 2024.

Don’t miss this chance to enhance your expertise and engage with a network of international specialists.

Webinar: Highlights of PRRT and drug development abstracts

Date: Wednesday, 26 June 2024

Time: 12:00 – 13:35 EDT / 18:00 – 19:35 CEST

Moderator: Rocío GARCIA-CARBONERO

 

ENETS education level:

Advanced

PART 1:
Nuclear medicine / PRRT abstracts

at 12:00 – 12:45 EDT / 18:00 – 18:45 CEST

Agenda

Opening - Rocío GARCIA-CARBONERO

Current trials (20 mins)

  • NETTER 2 trial (10 mins) – Francesa SPADA
  • Phase 2 Trial of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma: Interim Analysis Results (5 mins) - Alejandro GARCIA ALVAREZ
  • Neoadjuvant PRRT in pNET (NeoLuPaNET) (5 mins) - Alejandro GARCIA ALVAREZ

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocío GARCIA-CARBONERO, Emil LOU, Erik MITTRA, Frank LIN, Daniel HALPERIN, Stefano PARTELLI + presenters

Closing - Rocío GARCIA-CARBONERO

BREAK (5 minutes)

 

PART 2:
Multikinase Inhibitors / Drug development

at 12:50 – 13:35 EDT / 18:50 – 19:35 CEST

Agenda

Introduction - Emil LOU

Current trials (20 mins) - Shagufta SHAHEEN

  • CABINET trial
  • NATALIE in Pheo/para
  • (Combination MKI trials) Everolimus + Lenvatinib (ENETS) and CABATEN trial

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocio GARCIA-CARBONERO, Emil LOU, Camilo JIMENEZ + presenter

Closing - Emil LOU

 

Webinar: New insights, directions & signals

Date: Wednesday, 10 July 2024

Time: 12:00 – 12:45 EDT / 18:00 – 18:45 CEST

Moderator: Chandrikha CHANDRASEKHARAN

ENETS education level:

Advanced

Agenda

Opening - Chandrikha CHANDRASEKHARAN

Current trials (20 mins)

  • Paltusotine, 2 DLL3 trials and anti CD2000R1 – Jaume CAPDEVILA
  • Alphamedix, ACTION-1, and TECANT ERA – Daniel HALPERIN

Discussion (15 mins)
Panel: Tom HOPE, Chandrikha CHANDRASEKHARAN, Simona GLASBERG + presenters

Closing - Chandrikha CHANDRASEKHARAN

 

 

Watch this webinar on myENETS

You can stream the webinar directly on the myENETS platform. Please note that you will need to log into myENETS to watch this webinar. This webinar will be available in the ENETS webinar archive after the event.

The ENETS webinar series is free of charge and requires no registration – you don’t even need to be an ENETS member! All you need is a free ENETS account. Don’t have an ENETS account yet? Create one here.  

If you encounter any technical issues, please contact the ENETS Office at [email protected].

Advanced

Webinar: New insights, directions & signals

Date: Wednesday, 10 July 2024

Time: 12:00 – 12:45 EDT / 18:00 – 18:45 CEST

Moderator: Chandrikha CHANDRASEKHARAN

ENETS education level:

Advanced

Agenda

Opening - Chandrikha CHANDRASEKHARAN

Current trials (20 mins)

  • Paltusotine, 2 DLL3 trials and anti CD2000R1 – Jaume CAPDEVILA
  • Alphamedix, ACTION-1, and TECANT ERA – Daniel HALPERIN

Discussion (15 mins)
Panel: Tom HOPE, Chandrikha CHANDRASEKHARAN, Simona GLASBERG + presenters

Closing - Chandrikha CHANDRASEKHARAN

Webinar: Highlights of PRRT and drug development abstracts

Date: Wednesday, 26 June 2024

Time: 12:00 – 13:35 EDT / 18:00 – 19:35 CEST

Moderator: Rocío GARCIA-CARBONERO

 

ENETS education level:

Advanced

PART 1:
Nuclear medicine / PRRT abstracts

at 12:00 – 12:45 EDT / 18:00 – 18:45 CEST

Agenda

Opening - Rocío GARCIA-CARBONERO

Current trials (20 mins)

  • NETTER 2 trial (10 mins) – Francesa SPADA
  • Phase 2 Trial of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma: Interim Analysis Results (5 mins) - Alejandro GARCIA ALVAREZ
  • Neoadjuvant PRRT in pNET (NeoLuPaNET) (5 mins) - Alejandro GARCIA ALVAREZ

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocío GARCIA-CARBONERO, Emil LOU, Erik MITTRA, Frank LIN, Daniel HALPERIN, Stefano PARTELLI + presenters

Closing - Rocío GARCIA-CARBONERO

BREAK (5 minutes)

 

PART 2:
Multikinase Inhibitors / Drug development

at 12:50 – 13:35 EDT / 18:50 – 19:35 CEST

Agenda

Introduction - Emil LOU

Current trials (20 mins) - Shagufta SHAHEEN

  • CABINET trial
  • NATALIE in Pheo/para
  • (Combination MKI trials) Everolimus + Lenvatinib (ENETS) and CABATEN trial

Discussion (20 mins)
Panel: Eric BAUDIN, Jennifer CHAN, Rocio GARCIA-CARBONERO, Emil LOU, Camilo JIMENEZ + presenter

Closing - Emil LOU

 


Webinar: New insights, directions & signals

Date: Wednesday, 10 July 2024

Time: 12:00 – 12:45 EDT / 18:00 – 18:45 CEST

Moderator: Chandrikha CHANDRASEKHARAN

ENETS education level:

Advanced

Agenda

Opening - Chandrikha CHANDRASEKHARAN

Current trials (20 minutes)

  • Paltusotine, 2 DLL3 trials and anti CD2000R1 – Jaume CAPDEVILA
  • Alphamedix, Rayzebio, and TECANT ERA – Daniel HALPERIN

Discussion - Panel speakers: Tom HOPE, Chandrikha CHANDRASEKHARAN, Simona GLASBERG (15 minutes)

Closing - Chandrikha CHANDRASEKHARAN

 

 

Watch this webinar on myENETS

You can stream the webinar directly on the myENETS platform (https://my.enets.org/)


Please note that you will need to log into myENETS to watch this webinar.

The ENETS webinar series is free of charge and requires no registration – you don’t even need to be an ENETS member! All you need is a free ENETS account. Don’t have an ENETS account yet? Create one here.

If you encounter any technical issues, please contact the ENETS Office at info@enets.org.

This webinar will be available in the ENETS webinar archive after the event.